Mutations in the tyrosine kinase receptor trkB or in one of its natural ligands, brain-derived neurotrophic factor (BDNF), lead to severe hyperphagia and obesity in rodents and/or humans. Here, we show that peripheral administration of Neurotrophin-4 (NT4), the second natural ligand for trkB, suppresses appetite and body weight in a dose-dependent manner in several murine models of obesity. NT4 treatment increased lipolysis, reduced body fat content and leptin and elicited long lasting amelioration of hypertriglyceridemia and hyperglycemia. Following treatment termination, body weight gradually recovered to control levels in obese mice with functional leptin receptor. A single intrahypothalamic application of minute amounts of NT4 or an agonist trkB antibody also reduced food intake and body weight in mice. Taken together with the genetic evidence, our findings support the concept that trkB signaling which originates in the hypothalamus directly modulates appetite, metabolism and taste preference, downstream of the leptin and melanocortin 4 receptor (Mc4r). The trkB agonists mediate anorexic and weight reducing effects independent of stress induction, visceral discomfort or pain sensitization and thus emerge as a potential therapeutics for metabolic disorders.